<DOC>
	<DOCNO>NCT01466257</DOCNO>
	<brief_summary>RATIONALE : DNA analysis tumor tissue may help doctor predict well patient respond treatment . PURPOSE : This research study study biomarkers patient head neck cancer .</brief_summary>
	<brief_title>Biomarkers Patients With Head Neck Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To determine mutation rate HRAS PIK3CA patient head neck squamous cell carcinoma ( HNSCC ) treat cisplatin/placebo cisplatin/cetuximab protocol ECOG-E5397 . - To determine association HRAS PIK3CA mutation status clinical benefit ( i.e. , response , progression-free survival , overall survival ) patient treat cisplatin/cetuximab compare receive cisplatin/placebo protocol ECOG-E5397 . OUTLINE : DNA isolate one unstained slide per patient . The mutation HRAS PIK3CA determine use BEAMING technology .</detailed_description>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Treated protocol ECOGE5397 PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>metastatic squamous neck cancer occult primary squamous cell carcinoma</keyword>
	<keyword>recurrent metastatic squamous neck cancer occult primary</keyword>
	<keyword>recurrent squamous cell carcinoma hypopharynx</keyword>
	<keyword>recurrent squamous cell carcinoma larynx</keyword>
	<keyword>recurrent squamous cell carcinoma lip oral cavity</keyword>
	<keyword>recurrent squamous cell carcinoma oropharynx</keyword>
	<keyword>recurrent squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage III squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage III squamous cell carcinoma larynx</keyword>
	<keyword>stage III squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage III squamous cell carcinoma oropharynx</keyword>
	<keyword>stage III squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IV squamous cell carcinoma hypopharynx</keyword>
	<keyword>stage IVA squamous cell carcinoma larynx</keyword>
	<keyword>stage IVA squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IVA squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IVA squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IVB squamous cell carcinoma larynx</keyword>
	<keyword>stage IVB squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IVB squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IVB squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>stage IVC squamous cell carcinoma larynx</keyword>
	<keyword>stage IVC squamous cell carcinoma lip oral cavity</keyword>
	<keyword>stage IVC squamous cell carcinoma oropharynx</keyword>
	<keyword>stage IVC squamous cell carcinoma paranasal sinus nasal cavity</keyword>
	<keyword>untreated metastatic squamous neck cancer occult primary</keyword>
</DOC>